XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share Capital (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2023
Jun. 30, 2022
Mar. 31, 2022
Jan. 31, 2022
Oct. 31, 2021
Sep. 30, 2021
Mar. 31, 2021
Jan. 31, 2021
Jun. 30, 2020
Sep. 30, 2019
Mar. 31, 2018
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2018
Aug. 31, 2018
Share Capital [Line Items]                                
Warrants outstanding to purchase common stock                       2,173,081 3,103,864 2,775,996    
Options granted                       2,542,473 2,315,645 1,775,450    
Options Outstanding Weighted Average Remaining Contractual Life in Years                       7 years 4 months 24 days        
Options Exercisable Weighted Average Remaining Contractual Life in Years                       6 years 2 months 12 days        
Aggregate fair value of options vested                       $ 29,233 $ 13,752 $ 8,271    
Unrecognized stock-based compensation cost                       $ 70,691        
Unrecognized stock-based compensation expected to be recognized over a period                       2 years 7 months 9 days        
Number of warrants exercised                       (1,700,013) 0      
Warrants exercise description                       The Company may not affect the exercise of any pre-funded warrant, and a holder will not be entitled to exercise any portion of any pre-funded warrant that, upon giving effect to such exercise, would cause: (i) the aggregate number of common shares beneficially owned by such holder, together with its affiliates, to exceed 4.99% of the total number of common shares outstanding immediately after giving effect to the exercise; or (ii) the combined voting power of the Company’s securities beneficially owned by such holder, together with its affiliates, to exceed 4.99% of the combined voting power of all of the Company’s securities immediately outstanding after giving effect to the exercise, which percentage may be changed at the holder’s election to a higher or lower percentage not in excess of 19.99% upon at least 61 days’ notice to the Company.        
Term Loans [Member]                                
Share Capital [Line Items]                                
Warrants outstanding to purchase common stock                         40,000     40,000
Warrants exercise price per common share                               $ 9.79
Amended and Restated Stock Option Plan [Member]                                
Share Capital [Line Items]                                
Vesting period                       4 years        
Maximum term of each option exercised                       10 years        
Options granted                       0        
2019 Inducement Plan [Member]                                
Share Capital [Line Items]                                
Options granted                   0            
Common shares reserved for issuance                   400,000            
Amended and Restated 2014 Plan [Member]                                
Share Capital [Line Items]                                
Vesting period                 4 years              
Maximum term of each option exercised                 10 years              
Common shares reserved for issuance                 9,300,000     3,460,724        
Number of restricted share awards, restricted share unit awards or performance awards available for issue                 1,000,000              
Common Shares [Member]                                
Share Capital [Line Items]                                
Shares issued                       10,701,842 9,357,348 16,143,472    
Conversion of shares     1,016,000                   1,016,000   1,852,000  
Common stock issued upon conversion of pre-funded warrants                       1,700,000        
Pre-funded warrants exercised                       1,700,013        
March 2021                                
Share Capital [Line Items]                                
Warrants issued price per pre funded warrant                       $ 18.4999        
Warrants exercise price per common share                       $ 0.0001        
Number of warrants exercised                       (1,081,081)        
October 2021                                
Share Capital [Line Items]                                
Warrants issued price per pre funded warrant                       $ 29.4999        
Warrants exercise price per common share                       $ 0.0001        
Number of warrants exercised                       (618,932)        
June 2022                                
Share Capital [Line Items]                                
Warrants issued price per pre funded warrant                       $ 30.4999        
Warrants exercise price per common share                       0.0001        
December 2023                                
Share Capital [Line Items]                                
Warrants issued price per pre funded warrant                       32.4999        
Warrants exercise price per common share                       $ 0.0001        
Jefferies and Stifel [Member] | ATM [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares               $ 10,693       $ 29,508        
Jefferies and Stifel [Member] | ATM [Member] | Maximum [Member]                                
Share Capital [Line Items]                                
Gross proceeds from issuable of common stock                       $ 250,000        
Jefferies and Stifel [Member] | ATM [Member] | Common Shares [Member]                                
Share Capital [Line Items]                                
Shares issued               733,000       855,685        
Jefferies and Stifel [Member] | Underwritten Public Offering [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares             $ 107,922                  
Shares issued             5,135,135                  
Shares price             $ 18.50                  
Warrants outstanding to purchase common stock             1,081,081                  
Warrants issued price per pre funded warrant             $ 18.4999                  
Warrants exercise price per common share             $ 0.0001                  
Sale proceeds from issuance of pre funded warrants                       $ 23,477 $ 9,387 $ 65,716    
Jefferies and Stifel [Member] | Over Allotment [Member]                                
Share Capital [Line Items]                                
Shares issued             810,810                  
Jefferies LLC SVB Leerink LLC and Stifel Nicolaus Company Incorporated [Member] | Underwritten Public Offering [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares         $ 323,938                      
Shares issued         10,000,000                      
Shares price         $ 29.50                      
Warrants outstanding to purchase common stock         1,694,915                      
Warrants issued price per pre funded warrant         $ 29.4999                      
Warrants exercise price per common share         $ 0.0001                      
Jefferies LLC SVB Leerink LLC and Stifel Nicolaus Company Incorporated [Member] | Over Allotment [Member]                                
Share Capital [Line Items]                                
Shares issued         1,525,423                      
Neurocrine Biosciences [Member] | License and Collaboration Agreement [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares       $ 8,250   $ 5,500                    
Shares issued       258,986   275,337                    
Aggregate purchase price per share       $ 31.855   $ 19.9755                    
Premium       $ 374   $ 770                    
Jefferies, Stifel, J.P. Morgan Securities LLC and SVB Securities LLC [Member] | Underwritten Public Offering [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares   $ 269,890                            
Shares issued   9,098,362                            
Shares price   $ 30.50                            
Warrants outstanding to purchase common stock   327,868                            
Warrants issued price per pre funded warrant   $ 30.4999                            
Warrants exercise price per common share   $ 0.0001                            
Jefferies, Stifel, J.P. Morgan Securities LLC and SVB Securities LLC [Member] | Over Allotment [Member]                                
Share Capital [Line Items]                                
Shares issued   1,229,508                            
J.P. Morgan, Jefferies, BofA Securities, Inc., Stifel, and RBC Capital Markets, LLC [Member] | Underwritten Public Offering [Member]                                
Share Capital [Line Items]                                
Sale proceeds of common shares                       $ 323,979        
Shares issued 9,846,157                              
Shares price $ 32.5                              
Warrants outstanding to purchase common stock 769,230                              
Warrants issued price per pre funded warrant $ 32.4999                              
Warrants exercise price per common share $ 0.0001                              
J.P. Morgan, Jefferies, BofA Securities, Inc., Stifel, and RBC Capital Markets, LLC [Member] | Over Allotment [Member]                                
Share Capital [Line Items]                                
Shares issued 1,384,615                              
Series1 Preferred Shares                                
Share Capital [Line Items]                                
Conversion of shares     1,016,000                       1,852,000  
BVF Partners L.P [Member] | Exchange Agreement [Member] | Common Shares [Member]                                
Share Capital [Line Items]                                
Shares cancelled                     2,868,000          
BVF Partners L.P [Member] | Exchange Agreement [Member] | Series1 Preferred Shares                                
Share Capital [Line Items]                                
Preferred shares convertible into common shares                     one-for-one          
Shares issued                     2,868,000